Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

by Mohammad R. Nikmaneshi, Rakesh K. Jain, Lance L. Munn
Published 2023-06-01

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization.

by Mohammad R Nikmaneshi, Rakesh K Jain, Lance L Munn
Published 2023-06-01

Transport Barriers Influence the Activation of Anti‐Tumor Immunity: A Systems Biology Analysis

by Mohammad R. Nikmaneshi, James W. Baish, Hengbo Zhou, Timothy P. Padera, Lance L. Munn
Published 2023-12-01

Dynamic heterogeneity in COVID-19: Insights from a mathematical model.

by Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Lance L Munn, Rakesh K Jain, Triantafyllos Stylianopoulos
Published 2024-01-01

577 Cancer immunotherapy responses persist after lymph node resection

by Lance L Munn, Mohammad R Nikmaneshi, Laurel B Darragh, Sana D Karam, Pinji Lei, Hengbo Zhou, Meghan J O’Melia, James W Baish, Lutz Menzel, Johanna J Rajotte, Mohammad S Razavi Rizi, Matthew G Vander Heiden, Timothy P Padera
Published 2023-11-01